Really, folks...as a long time government administrator assume that this was a simple form letter response prepared for just these circumstances. Generex is the recipient of this form letter. Don’t read any more into it than what it says. Generex could employ the very best management in the history of the planet earth and the FDA would still have sent them this letter.

IMHO...the only things that are important are...in this order...(1) the S-1 response and (2) the results of the peptide investigation. Neither of these things are within management’s ability to influence. They are just as powerless as we are. I hope, only, that they are using this ‘waiting time’ usefully, building value in the rest of the company, and that is something I am interested in.